These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17240209)

  • 21. The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women.
    Yanik B; Bavbek N; Yanik T; Inegöl I; Kanbay M; Turgut FH; Uz E; Akçay A
    Ren Fail; 2007; 29(4):471-6. PubMed ID: 17497471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteocyte viability and regulation of osteoblast function in a 3D trabecular bone explant under dynamic hydrostatic pressure.
    Takai E; Mauck RL; Hung CT; Guo XE
    J Bone Miner Res; 2004 Sep; 19(9):1403-10. PubMed ID: 15312240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.
    Aguirre JI; Plotkin LI; Stewart SA; Weinstein RS; Parfitt AM; Manolagas SC; Bellido T
    J Bone Miner Res; 2006 Apr; 21(4):605-15. PubMed ID: 16598381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair.
    Sloan AV; Martin JR; Li S; Li J
    Bone; 2010 Aug; 47(2):235-40. PubMed ID: 20580684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro.
    Still K; Phipps RJ; Scutt A
    Calcif Tissue Int; 2003 Feb; 72(2):143-50. PubMed ID: 12457261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of in vivo mechanical loading on estrogen receptor alpha expression in rat ulnar osteocytes.
    Ehrlich PJ; Noble BS; Jessop HL; Stevens HY; Mosley JR; Lanyon LE
    J Bone Miner Res; 2002 Sep; 17(9):1646-55. PubMed ID: 12211435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo.
    Verborgt O; Gibson GJ; Schaffler MB
    J Bone Miner Res; 2000 Jan; 15(1):60-7. PubMed ID: 10646115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
    Iwata K; Li J; Follet H; Phipps RJ; Burr DB
    Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study.
    Racewicz AJ; Schofield PJ; Cahall DL; Cline GA; Burgio DE
    Curr Med Res Opin; 2007 Dec; 23(12):3079-89. PubMed ID: 17971285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae.
    Lanza F; Schwartz H; Sahba B; Malaty HM; Musliner T; Reyes R; Quan H; Graham DY
    Am J Gastroenterol; 2000 Nov; 95(11):3112-7. PubMed ID: 11095326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose risedronate sodium protects bone cells after abrupt oestrogen withdrawal.
    Wang G; Zhu Z; Lei C; Li M; Liu F; Mao Y; Yu Z; Liu M; Zhao X; Tang T
    J Int Med Res; 2012; 40(5):1761-74. PubMed ID: 23206458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.
    Mashiba T; Hirano T; Turner CH; Forwood MR; Johnston CC; Burr DB
    J Bone Miner Res; 2000 Apr; 15(4):613-20. PubMed ID: 10780852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation.
    Valenti MT; Giannini S; Donatelli L; Zanatta M; Bertoldo F; Sella S; Vilei MT; Ossi E; Realdi G; Lo Cascio V; Dalle Carbonare L
    Arthritis Res Ther; 2010; 12(4):R163. PubMed ID: 20738860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
    Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
    J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.
    Allen MR; Follet H; Khurana M; Sato M; Burr DB
    Calcif Tissue Int; 2006 Oct; 79(4):255-61. PubMed ID: 17033724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
    Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
    Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone.
    Noble BS; Peet N; Stevens HY; Brabbs A; Mosley JR; Reilly GC; Reeve J; Skerry TM; Lanyon LE
    Am J Physiol Cell Physiol; 2003 Apr; 284(4):C934-43. PubMed ID: 12477665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of raloxifene treatment on osteocyte apoptosis in postmenopausal women.
    van Essen HW; Holzmann PJ; Blankenstein MA; Lips P; Bravenboer N
    Calcif Tissue Int; 2007 Sep; 81(3):183-90. PubMed ID: 17676256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat.
    Jones MD; Tran CW; Li G; Maksymowych WP; Zernicke RF; Doschak MR
    Arthritis Rheum; 2010 Sep; 62(9):2726-35. PubMed ID: 20533290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats.
    Mosekilde L; Thomsen JS; Mackey MS; Phipps RJ
    Bone; 2000 Nov; 27(5):639-45. PubMed ID: 11062350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.